Price Alert

LeMaitre Vascular Inc. (LMAT)

NASDAQ: LMAT · Real-Time Price · USD

95.76

0.61 (0.64%)

At close: Aug 14, 2025, 3:59 PM

95.81

0.05%

After-hours: Aug 14, 2025, 05:52 PM EDT

0.64% (1D)

Bid	75
Market Cap	2.17B
Revenue (ttm)	234.64M
Net Income (ttm)	47.12M
EPS (ttm)	2.05
PE Ratio (ttm)	46.71
Forward PE	37.07
Analyst	Buy

Ask	96.88
Volume	163,007
Avg. Volume (20D)	156,324
Open	94.62
Previous Close	95.15
Day's Range	94.07 - 96.48
52-Week Range	71.42 - 109.58
Beta	0.79

About LMAT

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol LMAT

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LMAT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

LeMaitre Vascular has released their quartely earnings on Aug 5, 2025:

Revenue of $64.23M exceeds estimates by $1.66M, with 15.01% YoY growth.

EPS of 0.6 exceeds estimates by 0.03, with 13.21% YoY growth.

Next Earnings Release

LeMaitre Vascular Inc. is scheduled to release its earnings on Oct 30, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+8.91%

LeMaitre Vascular shares are trading higher after ... Unlock content with Pro Subscription

3 months ago

-12.79%

LeMatire Vascular shares are trading lower after the company reported Q1 EPS guidance below estimates and lowered its FY25 EPS guidance.

News

4 days ago · zacks.com

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

1 week ago · fool.com

LeMaitre (LMAT) Q2 Revenue Jumps 15%

1 week ago · seekingalpha.com

LeMaitre Vascular, Inc. (LMAT) Q2 2025 Earnings Call Transcript

LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants David B. Roberts - President & Director Dorian LeBlanc - Chief Financial Officer ...

1 week ago · zacks.com

LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.52 per share a year ago.

1 week ago · zacks.com

PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the...

1 month ago · seekingalpha.com

Don't Be Too Cute, Buy These 3 Dividend Growers Instead

We avoid very high-yielding stocks, as the best way to grow richer over time is to own a diversified basket of dividend growth stocks. Today, we're highlighting a leading alternative asset manager, a ...

1 month ago · seekingalpha.com

LeMaitre Vascular: Scaling Nicely As Global Demand Builds

LeMaitre's revenue and earnings continue to grow, though profit growth has moderated. The European launch of Artegraft and pending approval of XenoSure in China are key near-term catalysts. The portfo...